This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chinese Academy of Medical Sciences. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations of Pingping Zuo in Tumor Treatment
Introduction
Pingping Zuo is a notable inventor based in Beijing, China. She has made significant contributions to the field of medical science, particularly in the development of innovative treatments for tumors. Her work focuses on enhancing the efficacy of cancer therapies while minimizing side effects.
Latest Patents
Pingping Zuo holds a patent for an invention titled "HSP90 inhibitory peptide conjugate and application thereof in treating tumor." This invention discloses a conjugate constructed by linking a HSP90 inhibitory peptide to a cytotoxic agent via a linker. The conjugates possess triple anti-tumor effects, including targeted delivery, chemotherapy, and apoptosis promotion. This innovative approach can enhance anti-tumor efficacy, reduce the required dosage, and decrease the toxicity associated with the accumulation of chemotherapeutics.
Career Highlights
Pingping Zuo is affiliated with the Chinese Academy of Medical Sciences, where she conducts her research and development work. Her dedication to advancing cancer treatment has positioned her as a key figure in her field.
Collaborations
She collaborates with esteemed colleagues, including Yanyong Liu and Nan Yang, who contribute to her research efforts and the advancement of medical science.
Conclusion
Pingping Zuo's innovative work in developing HSP90 inhibitory peptide conjugates represents a significant advancement in tumor treatment. Her contributions are paving the way for more effective and safer cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile